Editor-in-Chief Profile

Xiaoyuan (Shawn) Chen, Ph.D.
Nasrat Muzayyin Professor in Medicine and Technology
Yong Loo Lin School of Medicine and College of Design and Engineering
National University of Singapore
Email:

Biography

Dr. Xiaoyuan (Shawn) Chen received his PhD in Chemistry from the University of Idaho (1999). After two postdocs at Syracuse University and Washington University in St. Louis, he started his Assistant Professorship in 2002 and then moved to Stanford in 2004. He was promoted to Associate Professor in 2008. He then moved to NIH in 2009 and became a Senior Investigator and Chief of the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. He is currently Nasrat Muzayyin Chair Professor in Medicine and Technology, Yong Loo Lin School of Medicine (Department of Diagnostic Radiology, Department of Surgery), College of Design and Engineering (Depart-ment of Chemical and Biomolecular Engineering, Department of Biomedical Engineering), and Faculty of En-gineering (Department of Pharmacy and Pharmaceutical Sciences), National University of Singapore. He is also the Director of the Nanomedicine Translational Research Program, and Research Director of the Clinical Imaging Research Centre of the NUS School of Medicine. Dr. Chen has published over 1000 peer-reviewed papers (H-index: 204, total citations > 153,000 based on google scholar as of November 20, 2024) and nu-merous books and book chapters. He is the founding editor of journal “Theranostics” (current IF = 12.4). He was elected as AIMBE Fellow (2017), SNMMI Fellow (2020), Member of European Academy of Sciences (EurASc, 2024), Member of Academia Europaea (MAE, 2024), and Member of Singapore National Academy of Science (SNAS, 2024), received JBN Trailblazer Award (2023), SNMMI Michael J. Welch Award (2019), ACS Bioconjugate Chemistry Lecturer Award (2016), NIH Director’s Award (2014), and NIBIB Mentor Award (2012). He became a member of the Advanced Materials Hall of Fame (2023). He is also the Past President of Chinese American Society of Nuclear Medicine and Molecular Imaging (CASNMMI), Past President of the Radiopharmaceutical Science Council (RPSC), Society of Nuclear Medicine and Molecular Imaging (SNMMI), and Past President of the Chinese American Society of Nanomedicine and Nanobiotechnology (CASNN).

Updated on 2024-11-21.